Asia Cannabis Corp. Confirms Patent Application Filed by Swysh Inc. in relation to Anti-Viral Treatments
March 30, 2020 – Calgary, AB: Asia Cannabis Corp. (“ACC” or the “Company”) (CSE:ASIA) announced the following corporate developments today: On March 13, 2020, ACC announced that it had entered into…
Asia Cannabis Corp. Enters Agreement With Swysh Inc. To Obtain Technology License For Asia Region; Announces Intention To Affect Name Change And Complete Private Placement
March 19, 2020 – Calgary, AB: Asia Cannabis Corp. (“ACC” or the “Company”) (CSE:ASIA) announced the following corporate developments today: ACC is pleased to announce that it has entered an agreement…
Asia Green Biotechnology Corp. Announces Passing of Johannes Kingma
August 14, 2023 – Calgary, AB: Asia Green Biotechnology Corp. (“Asia Green” or the “Company”) (CSE:ASIA) announces the passing of Mr. Johannes Kingma, a director and one of founders as…
Asia Green Biotechnology Corp. And Inplanta Biotechnology Ltd. Announce Grant Of Full Registration Of “Bountiful” Hemp Cultivar
May 5, 2021 – Calgary, AB: Asia Green Biotechnology Corp. (“Asia Green” or the “Company”) (CSE:ASIA) announced today that InPlanta Biotechnology Ltd. (“InPlanta”), the Company’s partner and licensor to it…
Asia Green Biotechnology Corp. Enters Memorandum Of Agreement With Agricultural College In Cambodia To Evaluate Hemp Production Potential
March 8, 2021 – Calgary, AB: Asia Green Biotechnology Corp. (“AGB” or the “Company”) (CSE:ASIA) announced today that the Company continues to successfully implement its business plan in SE Asia…
Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc.
CALGARY, AB / ACCESSWIRE / September 8, 2020 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx…
Asia Green Biotechnology Corp. Enters Technology License Agreement with Pathway Rx Inc. for Asia Region and Agrees to Assist in Initiating Clinical Trials
CALGARY, AB / ACCESSWIRE / August 18, 2020 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx…
Asia Green Biotechnology Corp. Updates Status Of Continuing Covid-19 Research Activity With License Partners
May 19, 2020 – Calgary, AB: Asia Green Biotechnology Corp. (“ASIA” or the “Company”) (CSE:ASIA) announced the following corporate developments today: On March 13, 2020, ASIA announced that it had…